ArticleFrontiers in psychiatry2025
Impact of comorbid depression on quality of life and disease progression in chronic obstructive pulmonary disease: a correlational analysis.
Article in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Exploring health consequences of Asthma-COPD overlap syndrome in a national study.Scientific reports · 2026Article
- Development and temporal prospective validation of an interpretable machine learning model for identifying depressive symptoms in patients with acute exacerbation of chronic obstructive pulmonary disease.Frontiers in public health · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Depression is a prevalent comorbidity in patients with Chronic Obstructive Pulmonary Disease (COPD), particularly during acute exacerbations (AECOPD), significantly impacting prognosis and quality of life. This study aimed to investigate the risk factors and severity of depression in this population. Objective: To identify risk factors and assess depression severity in patients experiencing Acute Exacerbation of Chronic Obstructive Pulmonary Disease (AECOPD). Methods: AECOPD patients admitted to Chaohu Hospital Affiliated with Anhui Medical University, between October 2023 and February 2025 were included. Participants were divided into four groups using the Patient Health Questionnaire-9 (PHQ-9): mild depression group (n=86), moderate depression group (n=24), severe depression group (n=3), and a control group without depression (n=156). Data collection involved: the first two domains of the World Health Organization Quality of Life questionnaire (WHOQOL-BREF), The Social Impact Scale (SIS) for stigma assessment Clinical data, treatment history, and laboratory test results. A custom-designed questionnaire was utilized to record hospitalization details for intergroup comparisons. Results: This study included 269 AECOPD patients, comprising 113 cases in the depression group and 156 controls. Comparative analysis revealed that female patients, those with longer smoking histories, theophyllines users, individuals with greater disease severity, stronger perceived stigma, and poorer quality of life demonstrated higher susceptibility to depression. In depression severity subgroups, 86 cases were classified as mild depression while 27 cases exhibited moderate-to-severe depression. The results demonstrated that gender, glucocorticoid use, daily cigarette consumption, and prolonged hospitalization were significantly associated with aggravated comorbid depression in COPD patients. Conclusion: Depressive state in patients with AECOPD is clinically common and associated with factors including gender, smoking history, MMRC grade, disease severity, hospitalization duration, theophyllines use, as well as quality of life and stigma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.